Emerging countries press for Covid-19 vaccine supply in poor nations | World News - Hindustan Times
close_game
close_game

Emerging countries press for Covid-19 vaccine supply in poor nations

AFP |
Jun 01, 2021 10:03 PM IST

The joint statement by the so-called "BRICS" group -- Brazil, Russia, India, China and South Africa -- followed an online summit chaired by India's Foreign Minister Subrahmanyam Jaishankar.

Five of the world's biggest emerging economies Tuesday called for the development and delivery of Covid-19 vaccines to be sped up, reiterating that measures such as waiving intellectual property rights over jabs could help poorer nations battle the pandemic.

South Africa's Foreign Minister Naledi Pandor earlier Tuesday reiterated Pretoria's position that "none of us are safe until all of us are safe".(Sanchit Khanna/HT File Photo)
South Africa's Foreign Minister Naledi Pandor earlier Tuesday reiterated Pretoria's position that "none of us are safe until all of us are safe".(Sanchit Khanna/HT File Photo)

The joint statement by the so-called "BRICS" group -- Brazil, Russia, India, China and South Africa -- followed an online summit chaired by India's Foreign Minister Subrahmanyam Jaishankar.

Hindustan Times - your fastest source for breaking news! Read now.

The foreign ministers said "extensive immunisation" would help bring the pandemic to an end, highlighting the "urgency for expeditious development and deployment of Covid-19 vaccines, especially in developing countries".

They also expressed support for the global campaign led by South Africa and India at the World Trade Organization to temporarily waive IP rights for Covid-19 vaccines.

Sharing vaccine doses, technology transfers, developing local production and supply chains as well as price transparency would also boost the fight against the infectious disease, the statement added.

South Africa's Foreign Minister Naledi Pandor earlier Tuesday reiterated Pretoria's position that "none of us are safe until all of us are safe".

Securing a waiver agreement "will allow use of intellectual property, the sharing of technologies and technology transfer," Pandor told the BRICS meeting, enabling "the production of vaccine therapeutics and wider distribution".

Supporters of the move argue it will spur production of low-cost generic vaccines, helping poor countries that are struggling to immunise their people.

The US under President Joe Biden has thrown its weight behind the bid alongside China, but other pharmaceutical heavyweights including the EU, Britain and Japan are reluctant.

Opponents argue waiving patents will damage intellectual property rights and erode the profit incentive, ultimately affecting pharmaceutical research and development.

Pharmaceutical companies also point out that manufacturing a vaccine requires know-how and technical resources which cannot be acquired at the flip of a switch.

Pandor, speaking by video link from Pretoria, said "millions of people in wealthier nations have been vaccinated, while billions of people in poorer countries still wait and are still vulnerable to infection, disease and death".

Just two percent of global vaccines have been administered in sub-Saharan Africa, according to WHO figures -- a situation that Pandor described as a "global gap of vaccine access".

Sixty-three countries have backed the Indian-South African proposal, but unanimity among all 164 WTO member states is needed for agreement.

Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now!

Get Latest World News along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On